MEEKER DAVID P (President and CEO) sold 17.3% of their position (50K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $5.13M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+50K
Price / share
$6.05
Trade value
$302.50K
% of position
Common Stock
Shares
−6.44K
Price / share
$101.75
Trade value
$655.15K
% of position
Common Stock
Shares
−30.75K
Price / share
$102.35
Trade value
$3.15M
% of position
Common Stock
Shares
−8.70K
Price / share
$103.43
Trade value
$899.63K
% of position
Common Stock
Shares
−1.82K
Price / share
$104.55
Trade value
$189.96K
% of position
Common Stock
Shares
−2.30K
Price / share
$105.19
Trade value
$241.94K
% of position
Net shares
+0.00
Net value
-$4.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | M · Option Exercise | +50K | $6.05 | $302.50K | 20.9% | 239.26K | 289.26K |
| Common Stock Direct | 9/14/2026 | S · Sale | −6.44K | $101.75 | $655.15K | 2.2% | 289.26K | 282.82K |
| Common Stock Direct | 9/14/2026 | S · Sale | −30.75K | $102.35 | $3.15M | 10.9% | 282.82K | 252.07K |
| Common Stock Direct | 9/14/2026 | S · Sale | −8.70K | $103.43 | $899.63K | 3.5% | 252.07K | 243.38K |
| Common Stock Direct | 9/14/2026 | S · Sale | −1.82K | $104.55 | $189.96K | 0.7% | 243.38K | 241.56K |
| Common Stock Direct | 9/14/2026 | S · Sale | −2.30K | $105.19 | $241.94K | 1.0% | 241.56K | 239.26K |
| Total | +0.00 | -$4.83M | ||||||
Employee Stock Option (Right to Buy)
Common Stock
50K shares
Shares
−50K
Strike price
6.05
Held after
15.43K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock50K shares | 9/14/2026 | M · Option Exercise | −50K | 6.05 | — | 15.43K |